Trials / Enrolling By Invitation
Enrolling By InvitationNCT06054178
Identification of Nerves Using Fluorescein Sodium
Intraoperative Nerve Identification With Fluorescein Sodium
- Status
- Enrolling By Invitation
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to see if there is benefit in using an IV contrast (sodium fluorescein) to identify nerves during head and neck surgery.
Conditions
- Pleomorphic Adenoma of the Parotid
- Warthin Tumor
- Head and Neck Disorder
- Head and Neck
- Thyroid Disease
- Thyroidectomy
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fluorescein Sodium | Intravenous administration of 1 mg/kg. If initial dosing is insufficient, additional doses may be administered up to a total of 3 mg/kg |
Timeline
- Start date
- 2024-11-07
- Primary completion
- 2025-07-01
- Completion
- 2025-09-01
- First posted
- 2023-09-26
- Last updated
- 2025-07-28
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06054178. Inclusion in this directory is not an endorsement.